After publishing The Diagnostics Reimbursement Compass: A 90-Minute Guide to Define, Demonstrate and Capture Diagnostics Value Confidently we have also created some short “explainer” videos.
Check out: #1 - Why does diagnostics access matter?
Diagnostic tests support many high-stake clinical decisions.
Tests and technologies are getting more complex (comprehensive genomic profiling, non-invasive prenatal testing, liquid biopsy, risk scores).
Digital diagnostic solutions further disrupt the status quo.
Clinical evidence requirements are increasing and linked to more stringent regulatory oversight.
Diagnostics reimbursement covers test reports and is mostly cost-based and not brand-specific. In many cases, laboratories and medical societies play a large role, and direct manufacturer engagement may be limited.
Reimbursement pathways are diverse with complex stakeholder groups involved.
Health technology assessments are not yet utilized consistently in the diagnostics field.
Cost containment for diagnostics is “knocking on the door.”